Gerhard Müller

Gerhard Müller has a extensive work history in the pharmaceutical industry. Gerhard is currently the Chief Scientific Officer at SpiroChem and has held the same role at Anavo Therapeutics BV. Prior to their current positions, they served as the Chief Scientific Officer at Gotham Therapeutics from 2017 to 2021. Gerhard has also worked at Mercachem BV as a Senior Vice President, where they were responsible for strategic expansion into medicinal chemistry services and project portfolio management. Before that, they held the role of Chief Scientific Officer and Managing Director at Proteros Fragments GmbH, where they expanded the company's offerings and established an understanding of the lead finding process. Gerhard also served as the Chief Scientific Officer at Axxima Pharmaceuticals AG and held various roles at N. V. Organon, Bayer AG, and GSK, where they focused on drug design and chemistry.

Gerhard Müller's education history begins in 1984 when they enrolled at Goethe University Frankfurt for their Bachelor's degree in organic chemistry. Gerhard successfully completed their studies and obtained their Master's degree in 1989.

After completing their Master's degree, Gerhard Müller further pursued their academic aspirations by attending the Technical University of Munich. From 1989 to 1992, they engaged in rigorous studies and research in the field of medicinal chemistry, ultimately earning their Doctor of Philosophy (Ph.D.) degree.

Throughout their educational journey, Gerhard Müller's focus primarily revolved around chemistry, with a specialization in organic and medicinal chemistry.